JP-2266

· Jeil Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JP-2266, covering 2023-11-22 to 2023-11-22. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Efficacy and Safety When Administered JP-2266 in Type 2 Diabetes Patients [Phase 2]